Oxford Immunotec Global PLC Ordinary Shares
OXFD
OXFD was delisted on the 5th of March, 2021.
60 hedge funds and large institutions have $400M invested in Oxford Immunotec Global PLC Ordinary Shares in 2020 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 21 increasing their positions, 28 reducing their positions, and 12 closing their positions.
43% more capital invested
Capital invested by funds: $280M → $400M (+$121M)
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
15% less funds holding
Funds holding: 71 → 60 (-11)
25% less repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 28
83% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ECM
Endurant Capital Management
San Mateo,
California
|
+$6.82M |
| 2 |
DM
Deerfield Management
New York
|
+$5.9M |
| 3 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
+$4.31M |
| 4 |
GPGA
Grandeur Peak Global Advisors
Salt Lake City,
Utah
|
+$2.82M |
| 5 |
Millennium Management
New York
|
+$2.69M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
-$10.7M |
| 2 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$6.85M |
| 3 |
PCM
Penn Capital Management
Philadelphia,
Pennsylvania
|
-$6.46M |
| 4 |
Renaissance Technologies
New York
|
-$2.02M |
| 5 |
WIC
Water Island Capital
New York
|
-$1.2M |
OXFD Hedge Fund Activity: Q4 2020 in Review
60 of the 5,676 institutional investors tracked by Wall St. Rank reported a position in Oxford Immunotec Global PLC Ordinary Shares (OXFD) for Q4 2020, worth a combined $400M — up 43% from $280M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of OXFD and 2 opened new positions — a net loss of 10 holders — while 28 trimmed existing stakes and 21 added.
The largest buyer was Endurant Capital Management, adding an estimated $6.82M. The largest seller was Alyeska Investment Group, cutting an estimated $10.7M.
- 60 institutional investors held Oxford Immunotec Global PLC Ordinary Shares (OXFD) as of Q4 2020, down from 71 in Q3 2020.
- Funds reported $400M of Oxford Immunotec Global PLC Ordinary Shares stock for Q4 2020, up 43% quarter-over-quarter.
- 2 funds opened new Oxford Immunotec Global PLC Ordinary Shares positions in Q4 2020 and 12 closed out, a net change of -10 holders.
- The largest Oxford Immunotec Global PLC Ordinary Shares buyer in Q4 2020 was Endurant Capital Management, an estimated $6.82M added.
- The largest Oxford Immunotec Global PLC Ordinary Shares seller in Q4 2020 was Alyeska Investment Group, an estimated $10.7M sold.
Based on aggregated 13F filings for Q4 2020.